A third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight, according to a major global study supported by the BRC.
UCLH has dosed the first UK participants in a study looking at alternating doses of different Covid-19 vaccines.
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
Researchers and children have produced a short animation explaining gene therapy.
Simple vision tests can predict which people with Parkinson’s disease will develop cognitive impairment and possible dementia 18 months later.
UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of the progressive condition hereditary motor neuropathy (HMN).
Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.
£1 million has been awarded to UCLH Charity from the Wolfson Foundation for research facilities in the new University College Hospital Grafton Way Building which is opening soon.
A new risk-stratification tool which can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19 has been developed by researchers.
UCLH has begun recruiting participants to a trial looking at whether two antiviral drugs given to people who have tested positive for Covid-19 can stop the virus replicating.
UCLH has welcomed the news that the Oxford-AstraZeneca coronavirus vaccine – which UCLH played a significant role in trialling – has today been approved for use in the UK.
UCLH researchers have recruited the first participant in the world to a study testing a long-acting antibody combination treatment to protect against Covid-19.
9 out of 10 people who have had mild or asymptomatic Covid-19 carry neutralizing antibodies 16-18 weeks after infection.
Men are almost three times as likely as women to be admitted to intensive care and have 40% higher odds of dying from Covid-19, according to a new study led by researchers at UCL, Great Ormond Street Hospital and the University of Cape Town.